Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 6-MTH group results

Nov 10 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              163.10              144.52           319.00    
                   (+12.9 pct)         (+11.0 pct)      (+5.8 pct)  
  Operating           16.36               12.21            20.50    
                   (+34.0 pct)        (+427.6 pct)      (-10.9 pct) 
  Recurring           19.08               17.34            25.00    
                   (+10.0 pct)        (+310.7 pct)      (-17.9 pct) 
  Net                  7.45               10.88            10.50    
                   (-31.5 pct)        (+274.0 pct)      (-44.7 pct) 
  EPS               90.89 yen          132.68 yen       128.09 yen  
  EPS Diluted       90.76 yen          132.52 yen                   
  Ann Div                              100.00 yen       100.00 yen  
  -Q2 div           50.00 yen           50.00 yen                   
  -Q4 div                               50.00 yen        50.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news